Works matching IS 08991987 AND DT 2023 AND VI 62 AND IP 3
Results: 10
UHRF1 plays an oncogenic role in small cell lung cancer.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 385, doi. 10.1002/mc.23493
- By:
- Publication type:
- Article
Atorvastatin shows antitumor effect in hepatocellular carcinoma development by inhibiting angiogenesis via TGF‐β1/pERK signaling pathway.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 398, doi. 10.1002/mc.23494
- By:
- Publication type:
- Article
KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 303, doi. 10.1002/mc.23487
- By:
- Publication type:
- Article
Circ‐E‐Cad encodes a protein that promotes the proliferation and migration of gastric cancer via the TGF‐β/Smad/C‐E‐Cad/PI3K/AKT pathway.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 360, doi. 10.1002/mc.23491
- By:
- Publication type:
- Article
Somatic A‐to‐I RNA‐edited RHOA isoform 2 specific‐R176G mutation promotes tumor progression in lung adenocarcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 348, doi. 10.1002/mc.23490
- By:
- Publication type:
- Article
DDIT4 promotes malignancy of head and neck squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 332, doi. 10.1002/mc.23489
- By:
- Publication type:
- Article
Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 319, doi. 10.1002/mc.23488
- By:
- Publication type:
- Article
KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 369, doi. 10.1002/mc.23492
- By:
- Publication type:
- Article
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 293, doi. 10.1002/mc.23486
- By:
- Publication type:
- Article
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2023, v. 62, n. 3, p. 289, doi. 10.1002/mc.23425
- Publication type:
- Article